Francisco X Real
Francisco X Real
Senior Group Leader, CNIO, Madrid; Professor of Cell Biology, Universitat Pompeu Fabra, Barcelona
Verified email at
Cited by
Cited by
A consensus molecular classification of muscle-invasive bladder cancer
A Kamoun, A de Reyničs, Y Allory, G Sjödahl, AG Robertson, R Seiler, ...
European urology 77 (4), 420-433, 2020
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
MI Canto, F Harinck, RH Hruban, GJ Offerhaus, JW Poley, I Kamel, Y Nio, ...
Gut 62 (3), 339-347, 2013
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
M García-Closas, N Malats, D Silverman, M Dosemeci, M Kogevinas, ...
The Lancet 366 (9486), 649-659, 2005
Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools
CM Villanueva, KP Cantor, JO Grimalt, N Malats, D Silverman, A Tardon, ...
American journal of epidemiology 165 (2), 148-156, 2007
Detectable clonal mosaicism and its relationship to aging and cancer
KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ...
Nature genetics 44 (6), 651-658, 2012
Addressing the challenges of pancreatic cancer: future directions for improving outcomes
M Hidalgo, S Cascinu, J Kleeff, R Labianca, JM Löhr, J Neoptolemos, ...
Pancreatology 15 (1), 8-18, 2015
Comprehensive transcriptional analysis of early-stage urothelial carcinoma
J Hedegaard, P Lamy, I Nordentoft, F Algaba, S Hřyer, BP Ulhři, S Vang, ...
Cancer cell 30 (1), 27-42, 2016
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
F Notta, M Chan-Seng-Yue, M Lemire, Y Li, GW Wilson, AA Connor, ...
Nature 538 (7625), 378-382, 2016
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
N Rothman, M Garcia-Closas, N Chatterjee, N Malats, X Wu, JD Figueroa, ...
Nature genetics 42 (11), 978-984, 2010
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
F Graus, J Dalmou, R Rene, M Tora, N Malats, JJ Verschuuren, ...
Journal of Clinical Oncology 15 (8), 2866-2872, 1997
Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4
PS Moore, B Sipos, S Orlandini, C Sorio, FX Real, NR Lemoine, T Gress, ...
Virchows Archiv 439, 798-802, 2001
Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma
SE Krown, FX Real, S Cunningham-Rundles, PL Myskowski, B Koziner, ...
New England Journal of Medicine 308 (18), 1071-1076, 1983
Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas
S Hernández, E López-Knowles, J Lloreta, M Kogevinas, A Amorós, ...
Journal of Clinical Oncology 24 (22), 3664-3671, 2006
Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage
M Porta, X Fabregat, N Malats, L Guarner, A Carrato, A De Miguel, L Ruiz, ...
Clinical and Translational Oncology 7, 189-197, 2005
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
N Malats, A Bustos, CM Nascimento, F Fernandez, M Rivas, D Puente, ...
The lancet oncology 6 (9), 678-686, 2005
Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma
CR Divgi, S Welt, M Kris, FX Real, SDJ Yeh, R Gralla, B Merchant, ...
JNCI: Journal of the National Cancer Institute 83 (2), 97-104, 1991
Epidemiology of urinary bladder cancer: from tumor development to patient’s death
C Murta-Nascimento, BJ Schmitz-Dräger, MP Zeegers, G Steineck, ...
World journal of urology 25, 285-295, 2007
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
BM Wolpin, C Rizzato, P Kraft, C Kooperberg, GM Petersen, Z Wang, ...
Nature genetics 46 (9), 994-1000, 2014
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
C Balbás-Martínez, A Sagrera, E Carrillo-de-Santa-Pau, J Earl, ...
Nature genetics 45 (12), 1464-1469, 2013
Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome
L Groesser, E Herschberger, A Ruetten, C Ruivenkamp, E Lopriore, ...
Nature genetics 44 (7), 783-787, 2012
The system can't perform the operation now. Try again later.
Articles 1–20